Clinical Trial Update: ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial update for ANG1005 in patients with breast cancer and brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• ANG1005 (GRN1005)

Snippet

Sponsor: Angiochem Inc | Conditions: Breast Cancer, Brain Metastases | Phase 2 | Status: COMPLETED